CYP2C9 and hepatocellular carcinoma: Time-series transcriptomic analyses in mouse models have demonstrated that CYP2C9 plays a critical regulatory role in HCC development by suppressing hepatocyte proliferation induced by liver injury through inhibition of the NF-κB signaling pathway.